Lantern Pharma Inc. (LTRN) Ownership
LTRN ownership summary
as of October 18, 2026- Institutions
- 17.3% of shares outstanding
- Insiders
- 17.36% of shares outstanding
- Shares outstanding
- 14.9M
- Float
- 10.7M shares available to trade
- Short interest
- 3.26% 486K shares short
- Days to cover
- 1.81 short interest down 12.9% vs prior month
- Institutions 17.30%
- Insiders 17.36%
- Other investors 65.34%
LTRN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LP | 5.64% | 843K | $562,903 | +842,669 (0.0%) | June 30, 2026 |
| 2 | CM Management, LLC | 3.35% | 500K | $334,000 | +250,000 (+100.0%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 2.85% | 425K | $283,979 | +93,039 (+28.0%) | June 30, 2026 |
| 4 | Renaissance Technologies Corp | 1.95% | 291K | $194,414 | +175,039 (+150.9%) | June 30, 2026 |
| 5 | BIOS CAPITAL MANAGEMENT, LP | 1.67% | 249K | $166,597 | −615,038 (−71.1%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.69% | 103K | $68,683 | −8,827 (−7.9%) | June 30, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.33% | 50K | $33,367 | +343 (+0.7%) | June 30, 2026 |
| 8 | Citadel Advisors Llc | 0.32% | 48K | $31,994 | +47,895 (0.0%) | June 30, 2026 |
| 9 | Westside Investment Management, Inc. | 0.32% | 48K | $31,964 | −2,200 (−4.4%) | June 30, 2026 |
| 10 | Quadrature Capital Limited | 0.27% | 40K | $26,448 | +39,593 (0.0%) | June 30, 2026 |
| 11 | Goss Wealth Management LLC | 0.18% | 27K | $18,069 | −350 (−1.3%) | June 30, 2026 |
| 12 | Horizon Asset Management Inc/ny | 0.17% | 25K | $16,810 | −1,209 (−4.6%) | June 30, 2026 |
| 13 | Davenport & Company LLC | 0.16% | 24K | $15,908 | — | June 30, 2026 |
| 14 | State Street Corp | 0.16% | 24K | $15,800 | — | June 30, 2026 |
| 15 | BlackRock Inc | 0.15% | 22K | $14,930 | −22,917 (−50.6%) | June 30, 2026 |
| 16 | Bank of New York Mellon Corp | 0.14% | 21K | $14,229 | — | June 30, 2026 |
| 17 | Northern Trust Corp | 0.12% | 17K | $11,680 | +1,896 (+12.2%) | June 30, 2026 |
| 18 | XTX Topco Ltd | 0.12% | 17K | $11,633 | +17,415 (0.0%) | June 30, 2026 |
| 19 | Dimensional Fund Advisors, Inc. | 0.11% | 17K | $11,172 | −21,335 (−56.1%) | June 30, 2026 |
| 20 | UBS Group AG | 0.11% | 17K | $11,110 | +6,555 (+65.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 1.5M shares and 7 cut 672K.
LTRN top mutual fund and ETF holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.27% | 338K | $226,041 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.33% | 49K | $32,976 | +4,353 (+9.7%) | August 31, 2026 |
| 3 | Abante Quant Value FI | 0.24% | 35K | $23,642 | — | July 31, 2026 |
| 4 | Horizon Kinetics Medical ETF | 0.15% | 23K | $15,194 | — | September 30, 2026 |
| 5 | Fidelity Series Total Market Index | 0.12% | 17K | $11,675 | — | August 31, 2026 |
| 6 | Fidelity Total Market Index | 0.10% | 15K | $10,202 | — | August 31, 2026 |
| 7 | Vanguard Balanced Index Inv | 0.03% | 4,832 | $3,228 | — | August 31, 2026 |
| 8 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 2,355 | $1,573 | — | August 31, 2026 |
| 9 | Dimensional US Sustainability Core 1 ETF | 0.01% | 1,924 | $1,285 | — | September 30, 2026 |
| 10 | DFA US Core Equity Class F | 0.01% | 1,805 | $1,206 | −1,851 (−50.6%) | July 31, 2026 |
| 11 | Dimensional Gl Cor Eq LC ESG Sc USD A | 0.01% | 1,677 | $1,120 | — | August 31, 2026 |
| 12 | Dimensional US Core Equity 2 ETF | <0.01% | 643 | $430 | — | September 30, 2026 |
| 13 | Dimensional US Core Equity USD Acc | <0.01% | 284 | $190 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LTRN insider transactions
latest 14| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-13 | Aaron G.L. Fletcher | Sell | $3.09 | 40,000 | $123,600 |
| 2025-06-13 | Leslie W Kreis | Sell | $3.09 | 40,000 | $123,600 |
| 2025-06-12 | Aaron G.L. Fletcher | Sell | $3.38 | 60,647 | $204,987 |
| 2025-06-12 | Leslie W Kreis | Sell | $3.38 | 60,647 | $204,987 |
| 2025-06-11 | Aaron G.L. Fletcher | Sell | $3.40 | 950 | $3,230 |
| 2025-06-11 | Leslie W Kreis | Sell | $3.40 | 950 | $3,230 |
| 2025-06-10 | Aaron G.L. Fletcher | Sell | $3.40 | 16 | $54 |
| 2025-06-10 | Leslie W Kreis | Sell | $3.40 | 16 | $54 |
| 2025-05-29 | Aaron G.L. Fletcher | Sell | $3.03 | 20,200 | $61,206 |
| 2025-05-29 | Leslie W Kreis | Sell | $3.03 | 20,200 | $61,206 |
| 2025-05-28 | Aaron G.L. Fletcher | Sell | $2.87 | 15,000 | $43,050 |
| 2025-05-28 | Leslie W Kreis | Sell | $2.87 | 15,000 | $43,050 |
| 2025-05-27 | Aaron G.L. Fletcher | Sell | $3.05 | 21,037 | $64,163 |
| 2025-05-27 | Leslie W Kreis | Sell | $3.05 | 21,037 | $64,163 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LTRN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LTRN
Institutional investors own 17.3% of Lantern Pharma's shares and insiders 17.36%. The largest holder is Empery Asset Management, LP with 5.64% of the shares (843K), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 7 reduced their stake in the latest filings. Short interest is 3.26% of the float, or 1.81 days of average trading volume. The share count rose 75.3% since 2019.
Related: LTRN analyst forecast, LTRN key metrics. See the LTRN stock overview for the latest quote and news.
LTRN ownership FAQ
Who owns the most Lantern Pharma stock?
The largest shareholders of Lantern Pharma are Empery Asset Management, LP (5.64%), CM Management, LLC (3.35%), Vanguard Capital Management, LLC (2.85%), Renaissance Technologies Corp (1.95%), BIOS CAPITAL MANAGEMENT, LP (1.67%).
What percentage of Lantern Pharma is owned by institutions?
Institutions hold 17.3% of Lantern Pharma's shares outstanding; insiders hold 17.36%.
Which funds own Lantern Pharma?
The largest fund holders of Lantern Pharma are Vanguard MStar Total Stk Mkt Idx Invest (2.27%), Fidelity Extended Market Index (0.33%), Abante Quant Value FI (0.24%), Horizon Kinetics Medical ETF (0.15%), Fidelity Series Total Market Index (0.12%).
What is Lantern Pharma's short interest?
486K shares of Lantern Pharma were sold short, 3.26% of the float; at the average daily volume it would take 1.81 days to cover.
Are insiders buying or selling Lantern Pharma?
Of the latest 14 reported insider transactions in Lantern Pharma (since May 27, 2025), 0 were purchases and 14 were sales.
How many shares of Lantern Pharma are outstanding?
Lantern Pharma has 14.9M shares outstanding, of which 10.7M are in the public float.